BOSTON SCIENTIFIC CORPORATION (BSX) /

The cash flow of BOSTON SCIENTIFIC CORPORATION over the past 10 years

Chart BOSTON SCIENTIFIC CORPORATION: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, BOSTON SCIENTIFIC CORPORATION's operating cash flow was $4.53B and its capital expenditures $876M, leaving free cash flow of $3.66B. Free cash flow was above zero in 9 of the 10 years shown. It ranged from -$6M in fiscal 2018 to $3.66B in fiscal 2025. Capital expenditures were highest in fiscal 2025, at $876M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$4.53B$876M$3.66B
2024ended Dec 31, 2024$3.44B$790M$2.65B
2023ended Dec 31, 2023$2.5B$711M$1.79B
2022ended Dec 31, 2022$1.53B$588M$938M
2021ended Dec 31, 2021$1.87B$554M$1.32B
2020ended Dec 31, 2020$1.51B$376M$1.13B
2019ended Dec 31, 2019$1.84B$461M$1.38B
2018ended Dec 31, 2018$310M$316M-$6M
2017ended Dec 31, 2017$1.43B$319M$1.11B
2016ended Dec 31, 2016$1.18B$376M$806M

Fiscal years as BOSTON SCIENTIFIC CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on BOSTON SCIENTIFIC CORPORATION

Companies of a similar size

Not investment advice. This page shows what BOSTON SCIENTIFIC CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.